Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 15 in /home/dev/public_html/wp-content/themes/pru2.0/amp/single.php on line 52
Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 15 in /home/dev/public_html/wp-content/themes/pru2.0/amp/single.php on line 52
StemGenex is accepting new patients with various medical conditions, especially Alzheimer’s disease. The company, www.stemgenex.com, offers human stem cell treatment which they coined as The Human Repair Kit. Alzheimer’s Patients now have a real choice when it comes to their individual treatment plans. StemGenex is employing adult stem cells to potentially slow down, if not stop, the onset or existing battle against neurological diseases, such as Alzheimer’s.
Part of StemGenex’s treatment is public education. Most people are not aware of the vast differences between fetal and embryonic stem cells vs. adult stem cells. Adult stem cells, are used by StemGenex for patients with various disorders, such as Alzheimer’s, Parkinson’s, Multiple Sclerosis, and COPD. Through intense, continued research, the company has facilitated the concept of using adipose tissue (fat) which hold an abundant supply of dormant adult stem cells, for new techniques when treating a range of medical ailments. The stem cell treatments employed by StemGenex are safe, natural and require no dangerous anesthesia.
“Nancy Regan was one the first to engage the idea of using stem cells to fight Alzheimer’s disease. Her impact on our industry is continually referenced, even up to earlier this week in The Huffington Post.” said Rita Alexender of StemGenex. “At the present time, the cause and progress of Alzheimer’s disease is not fully understood. However, StemGenex has had remarkable success with the Alzheimer’s patients we have treated. Our dedication to continuously offer advanced stem cell treatments and identify the causes and effects associated with certain neurological diseases is one of our highest priorities.”
According to the Alzheimer’s Association, an estimated 5.4 million people in The United States alone suffer from Alzheimer’s disease, resulting in over 184 billion dollars in medical costs. StemGenex is offering a revolutionary treatment that offers both hope and a long-term financial tourniquet to the country’s runaway medical spending runaway medical spending crisis. StemGenex wants potential patients, and the media, to know they have a real and natural alternative when it comes to combating neurological diseases, such as Alzheimer’s.
StemGenex is a division of the International Stem Cell Institute (ISCI). Together, StemGenex and ISCI are developing tactical connections with researchers and leaders in the stem cell industry. Through both divisions working towards a unified goal to continue their persistent research in this field, StemGenex and ISCI are also considering working with a variety of prestigious universities and medical groups to accelerate further exploration of the many benefits associated with adult and adipose–derived stem cells.
A full EPK, company representative interview, and tear sheet with clinical locations for both StemGenex and ISCI can be provided for all story requests.
PUBLIC CONTACT:
StemGenex
www.StemGenex.com
800-609-7795
MEDIA CONTACT:
Helene Vece
Helene@JumpStartInk.com
(702)529-0290, Ext 4
